Viemed Healthcare (VMD) Cash from Financing Activities (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Cash from Financing Activities data on file, last reported at -$6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 271.19% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at -$10.4 million (down 156.85% YoY), and the FY2025 full-year result was -$5.8 million, down 56.93% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$6.3 million, up from -$8.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $11.3 million in Q2 2023 and bottomed at -$8.5 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is -$2.3 million (2022), against an average of -$1.7 million.
• The widest annual swing landed in 2023, when Cash from Financing Activities jumped 301.72%; it then plunged 3535.9% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$4.9 million in 2022, then surged by 37.78% to -$3.0 million in 2023, then surged by 113.33% to $404000.0 in 2024, then slumped by 2191.83% to -$8.5 million in 2025, then increased by 25.16% to -$6.3 million in 2026.
• The last three Cash from Financing Activities figures came in at -$6.3 million (Q1 2026), -$8.5 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.

Peer Comparison